Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

By Chandramohan Vidyalakshmi   Mitchell Duane A   Johnson Laura A   Sampson John H   Bigner Darell D  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 977-990

Future Medicine

Access to resources Recommend Favorite

Antigen analogs as tools to study T-cell activation function and activation

By Sette A.   Alexander J.   Snoke K.   Grey H.M.  

Seminars in Immunology, Vol. 8, Iss. 2, 1996-02 ,pp. : 103-108

Academic Press

Access to resources Recommend Favorite

Polyclonal T-cell activation protocol stimulates preferential expansion of EBV-specific T-cell clones in vitro

By Hedfors Ida   Brinchmann Jan  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 5, 2004-05 ,pp. : 439-444

Springer Publishing Company

Access to resources Recommend Favorite

Tumor-derived CD4⁺CD25⁺ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10

By Larmonier Nicolas   Marron Marilyn   Zeng Yi   Cantrell Jessica   Romanoski Angela   Sepassi Marjan   Thompson Sylvia   Chen Xinchun   Andreansky Samita   Katsanis Emmanuel  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 48-59

Springer Publishing Company

Access to resources Recommend Favorite

Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses

By Lundqvist Andreas   Palmborg Andreas   Bidla Gawa   Whelan Mike   Pandha Hardev   Pisa Pavel  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 155-165

Humana Press, Inc

Access to resources Recommend Favorite